Community Pharmacy England (CPE) - News updates

View the first article on NMS myth busting The post NMS myth busting series (#2) appeared first on Community Pharmacy England.

MHRA Class 4 Medicines Defect Notification: balance 2.3% glucose, 1.25 mmol/l calcium, solution for peritoneal dialysis (Fresenius Medical Care Deutschland GmbH) DMRC reference number: DMRC- 39439934 Date issued: 14 May 2026 Fresenius Medical Care Deutschland GmbH have identified an error in the Braille printed on the outer label. Marketing Authorisation Holder: Fresenius Medical Care Deutschland GmbH [...] The post MHRA Class 4 Medicines Defect Notification: balance 2.3% glucose, 1.25 mmol/l calcium, solution for peritoneal dialysis (Fresenius Medical Care Deutschland GmbH) appeared first on Community Pharmacy England.

    The post NMS myth busting series (#1) appeared first on Community Pharmacy England.

Community Pharmacy England’s annual regional roadshow series returns in less than a month, kicking off with events in Yorkshire & the North East in the first week of June. The series of interactive evening sessions will bring local pharmacies together with the people negotiating on their behalf to talk openly about funding, the challenges facing [...] The post We’re coming to a town near you appeared first on Community Pharmacy England.

MHRA Class 4 Medicines Defect Notification: Loperamide hydrochloride 2 mg Orodispersible Tablets (Milpharm Ltd) Drug alert number: EL(26)A/23 Date issued: 11 May 2026 Milpharm Limited has identified a discrepancy in the Patient Information Leaflet (PIL) approved for Loperamide hydrochloride 2 mg Orodispersible Tablets. DMRC reference number: DMRC- 39394163 Marketing Authorisation Holder: Milpharm Limited Medicine Details Product name: [...] The post MHRA Class 4 Medicines Defect Notification: Loperamide hydrochloride 2 mg Orodispersible Tablets (Milpharm Ltd) appeared first on Community Pharmacy England.

NHS IT teams want to learn how community pharmacy owners and decision makers decide which services IT system to use or move towards when system decisions are being made. The aim would be to help pharmacy owners choose pharmacy IT systems and services (e.g. a Pharmacy First IT solution) more easily, in a clearer and [...] The post IT system selection survey appeared first on Community Pharmacy England.

The MHRA has reviewed the evidence for finasteride and dutasteride and the risk of suicidal thoughts and behaviours and has recommended further measures to minimise this risk. The MHRA has reviewed the evidence for finasteride and dutasteride and the risk of suicidal thoughts and behaviours and has recommended further measures to minimise this risk. The product [...] The post MHRA Drug Safety Update: Finasteride and Dutasteride – updated safety warnings appeared first on Community Pharmacy England.

Eligible pharmacists in the East and North Midlands have been invited to express interest in joining Community Pharmacy England’s Committee. Expressions of Interest are now being sought as part of the mid-term election process for an ‘Independent regional representative’ for Community Pharmacy England’s East and North Midlands region. Interested LPC members or officers in the [...] The post Expressions of interest open for East and North Midlands Representative appeared first on Community Pharmacy England.

NHS England has updated its national standards on how pharmacy teams and IT system suppliers process nominations. This follows renewed scrutiny of nomination practices and reinforces the principle that patients must be able to set or change their nomination freely, without pressure or unwanted intervention. Nomination standards: Key points The four overarching standards: Patients must [...] The post NHS updates EPS nomination standards appeared first on Community Pharmacy England.

The Department of Health and Social Care (DHSC) has today (05/05/2026) confirmed the following final list of price concessions for April 2026: Drug Pack size Price concession Candesartan 32mg tablets 28 £1.57 Candesartan 4mg tablets 7 £0.75 Dapagliflozin 10mg tablets 28 £6.30 Labetalol 200mg tablets 56 £17.87 Lacidipine 4mg tablets 28 £1.95 Phenobarbital 15mg tablets 28 [...] The post April 2026 Price Concessions Final Update appeared first on Community Pharmacy England.